Revelation Partners

We focus on investment opportunities within the healthcare and life science markets where we can identify value early. At the core of our investment philosophy is a committed and collaborative approach to working with management teams and syndicate partners to build successful companies. We work actively with founders, providing guidance, support and access to our network. We strongly believe that no two investments are the same and support the most suitable business model for each individual venture, working with management teams to formulate strategies to achieve financial independence. We are comfortable financing companies by ourselves and, if appropriate, working closely with the founders to help build a syndicate of co-investors who bring complementary relationships and share our vision. We have a 14-year history of continuous dedication to the fast growing MedTech sector and a history of backing successful entrepreneurs transforming healthcare through MedTech innovation. Investment Strategy Focus: Within the broader healthcare market, we focus our investments on medical technologies including medical devices, diagnostics, drug delivery, and digital health. We back both first-time and experienced founders, who value our participation as well our capital. Stage: We are typically the first institutional investor and support companies through early product and clinical development and often through the regulatory process. We make our first investment at the seed through series B stage, based on when the risk of translation from pre-clinical to clinical is at its lowest. We are life cycle investors and continue to support our portfolio companies through to exit. Capital Efficiency: We invest in companies that are able to demonstrate early and meaningful clinical value with minimum capital invested and preserve the most appropriate exit opportunity. Therapeutic Indications: While we are agnostic to therapeutic indication, we invest in companies developing products that address large, global markets and where there is significant unmet clinical need. We particularly like therapeutic devices that significantly improve patient outcomes and diagnostics that fundamentally change the course of therapeutic intervention.

AGP is a fund management company spun out from EDBI, a state-owned fund in Singapore, with former senior employees as founders. The fund will continue to have close affiliation to EDBI providing unique opportunities for collaboration and investments. We are raising a dedicated healthcare fund (“AGP Healthcare Fund” or “AGPHC”) to build on our successes at EDBI and to capture new opportunities. Our partners have a credible reputation built on years of working together at EDBI and having strong domain expertise in healthcare, with extensive network and deep linkages to the Singapore, regional, and global biomedical and healthcare ecosystem. Our investment areas* include medtech & manufacturing, services & others, healthtech, and biotech & therapeutics. At AGP Healthcare Fund, we focus on investing in growth-stage companies (Series C to pre-IPO) (~75%) and venture-stage companies (Series A and B) (~25%). Our unique position in serving both SEA/Asia and global markets is driven by our belief that SEA is an emerging innovation hub with tremendous potential to build differentiated and valuable healthcare companies. We see opportunities for healthcare companies to capitalize on the Asian growth momentum by leveraging Singapore's position as a nexus between the East and the West. With our global insights and proven track record, we provide valuable guidance and advice to founders in expanding their businesses globally. Investment areasMedtech & Mfg, Services & Others: minimally invasive devices, medical equipment manufacturing & distribution, surgical robotics, diagnostics, healthcare services, new modalities CRDMOs, life science equipment & consumables, drug manufacturing & distribution Healthtech: remote patient monitoring, virtual care delivery, digital health platform, workflow automation, healthcare analytics, AI in healthcare imaging, digital therapeutics, chronic disease management Biotech & Therapeutics: cell & gene therapy, RNA therapeutics, AI drug discovery, targeted therapy & immunotherapy, gene editing tools & infrastructure, regenerative medicine & tissue engineering, and life science tools

At Flare Capital, we do more than simply provide capital for early stage and emerging healthcare technology companies. We partner with the most creative and passionate entrepreneurs aspiring to reinvent the business of healthcare. Together we work to build transformational companies that will profoundly improve the delivery and quality of healthcare while reducing costs. Our Team In 2014, Michael and Bill came together with the vision to build the leading dedicated healthcare technology venture capital firm. Both had started successful venture firms earlier in their careers and had a shared perspective on what the market now needed. As the “business of healthcare” is being transformed, there are significant opportunities to create important and enduring new healthcare technology companies. Given the complexity of this sector, a focused investment strategy with an experienced, committed team is required, and thus Flare Capital was launched. The firm is comprised of a number of proven healthcare technology investors with both deep industry knowledge and venture capital experience alongside accomplished operating executives of leading healthcare organizations. Our Executive Partners have substantial operating experience and our Industry Advisory Board includes many of the brightest healthcare minds with unique perspectives from across the industry. Together they provide critical insights and points of connectivity for our team at Flare Capital and are a tremendous resource for our entrepreneurs. Our Flare Scholars are professionals from preeminent healthcare companies and students from academic institutions across the country who scout interesting people and investment opportunities for us while learning about venture capital. Our Investors We have hand-assembled some of the most successful healthcare organizations, leading family offices, pension funds and investment companies as investors. At Flare Capital, we are privileged to partner with and have unparalleled access to leading innovative healthcare providers, payers, medical device companies, laboratory services provider, healthcare retailer, and one of the largest owners of healthcare campuses. Our investors have an enormous footprint in healthcare and are on the forefront of healthcare innovation. Our Approach We invest across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country. While we consider ourselves principally early stage investors, we are full lifecycle investors. We partner with our entrepreneurs across the entire journey of company building. We are committed to our entrepreneurs and to being their first call, as we work closely and patiently through all strategic issues confronting our companies, maximizing their probability of success. In particular, we are very focused on assisting with recruiting and securing early customer validation and revenues. Starting and then scaling a successful healthcare technology company is hard. Careful and thoughtful financing strategies need to map to detailed product development timelines and other commercial milestones. We closely collaborate with our entrepreneurs to ensure that they have critical access to the best resources as the business scales. We relentlessly strive to be a true partner and to deliver extraordinary value to our entrepreneurs to enable them to build market leading, transformational businesses.

Intuitive Ventures invests in and accelerates the digital, therapeutic, diagnostic, and device ecosystems of minimally invasive care. Our unique access to Intuitive’s industry-leading knowledge, care delivery innovation, and commercial reach, empowers us to cultivate the potential of startups that are advancing positive outcomes in healthcare. Through our inaugural $100 million fund, Intuitive Ventures is focused on accelerating the future of minimally invasive care by moving the ecosystem forward. What we do Intuitive Ventures extends Intuitive's commitment to converging robotic systems, digital tools, and clinical need in search of new ways to understand, diagnose, treat, and manage disease. We apply Intuitive’s strengths and abilities in the fields of robotic surgery and minimally invasive care to support independent initiatives in four focus areas: Digital – transformative business models and solutions improving outcomes across the patient care continuum Therapeutics – precision focal therapeutics and biotech innovations delivered to the right patient at the right place and the right time Diagnostics – powering earlier disease detection and therapeutic activation across clinical pathways Devices – novel and digitally-native medical device platforms pushing the boundaries of patient care What sets us apart: Aligned for success – our nimble structure and financial alignment empower us to invest early and to support our portfolio companies pioneer markets Wealth of experience – we provide the resources and guidance needed to support our entrepreneurs and management teams reach their major milestones Deep strategic value – we leverage the unique strengths of Intuitive to accelerate the impact of our portfolio companies

Founded over 20 years ago, Kaiser Permanente Ventures has developed into a national leader in strategic venture investing in healthcare. In partnership with Kaiser Permanente and our limited partners, the KPV team has invested in and helped support over 65 companies, representing some of the most important innovations in healthcare delivery over this time period. We’ve achieved these successes through deep engagement within KP and across our investment partners, leveraging the tremendous insights that come from those leading our healthcare systems and care delivery to identify the most pressing needs within healthcare and select the innovations that most effectively address those opportunities. Together with our partners, KP and KPV represents22,000+ clinicians and over 180,000 healthcare employees 38+ acute care hospitals and over 600 other healthcare-related facilities Approximately $65 billion in annual operating revenue Largest U.S. single comprehensive electronic medical record system Leading evidence-based care delivery mode Our fund targetsHealth Information Technology (Enterprise Solutions) Digital Health Healthcare Services Medical Devices Diagnostics and Precision Medicine

Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly. Why Choose Us Founded in 2006, Qiming Venture Partners is a leading global venture capital firm. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our establishment, Qiming Venture Partners has earned extensive recognition from investors worldwide and has become an ideal VC firm for entrepreneurs, due to our exceptional investment performance. Qiming Venture Partners and our partners consistently rank among the leaders in the global venture capital industry across various prestigious lists. Experienced Investment Team Our professional investment team consists of founders, entrepreneurs, scientists, engineers, doctors, consultants, and financial experts. We have extensive experiences in building and operating a business. We are happy to share our experiences and resources with entrepreneurs. Exceptional Investment Performances Qiming strives to be the preferred investor for top entrepreneurs. For the past decades, we seized the opportunity of changing world with technologies. We have invested in companies that later become industry unicorns and listed companies, which delivered excellent returns for our LP investors. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu (NYSE:ZH, SEHK:2390), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE:603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), New Horizon Health (SEHK:6606), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE:688520), UBTech (SEHK:9880), Yuanxin Technology, Caidya, Belief BioMed, WeRide, among many others. Adequate Resources and Experiences to Help Grow a Start-up to an Enterprise We always fully respect entrepreneurs. We are entrepreneurs' companions along their way of achieving dreams and building great companies. We leverage our industry resources to provide a broad range of support to entrepreneurs. We have built a unique Qiming ecosystem that can provide value-added services to portfolio companies, which creates beautiful chemistries between our portfolio companies. More and more new investments are made from the upstream or downstream of our portfolio companies, or from the recommendations of the portfolio companies. Increasing more of our portfolio companies started to cooperate intensively with each other. We help entrepreneurs make strategically critical decisions. When entrepreneurs are at a crossroads, we do our best to help them choose the right direction. We share industry insights with entrepreneurs so that they can better navigate the business world. We share our industry resources to entrepreneurs. Our extensive network in both East and West enables entrepreneurs with diversified resources, which helps them optimize their business model and become an industry leader. We help portfolio companies build strong teams and provide them with consulting support. We help entrepreneurs improve the leadership capacities and find their core team members to become long-term partners. We can connect entrepreneurs with management, finance, legal, and marketing professionals. We value important milestones such as financing, IPOs and M&As. We respect entrepreneurs with their own choices regarding the timing, location and approaches of financial activities. We work hand-in-hand with entrepreneurs, help them select the appropriate intermediaries, and sort out the strategic positioning, market scale, business structure and growth potential for the companies. Investment Strategies We are committed to finding great companies for the future and bring long-term value to societies. Our investment team spends a lot of time researching industry trends, technology developments, and changes in consumer habits. Through these studies, we hope to capture a huge future market as early as possible. At the same time, we also attach great importance to in-depth and detailed due diligence. We make comprehensive contact with entrepreneurs, through a deep understanding of the business operations and scientific research data, we can better grasp investment opportunities and assess investment risks. Another essential component of our investment strategy is “focus”. We hope to have good insights and rich contacts for the industries we care about, truly understand the projects we invested in, be able to help after the investment, and form an ecosystem within our portfolio companies, to help start-ups grow from multiple perspectives. What Do We Invest Since our inception in 2006, we have been in touch with tens of thousands of founding teams of startup companies. On average, one out of 30 companies receives our funding. Seventy percent of our investments are in Series-A, and many of our portfolio companies will become industry leaders in less than seven years. T&C: We invest in information technology and new consumer business patterns. We focus on mobile internet, social networking, and entertainment. We value how technology redefines business, education, and transport. We pay close attention to new core technologies, including artificial intelligence, robotics, semiconductors, enterprise software, blockchain and so forth. We have great interests in manufacturing upgrade opportunities. Healthcare: We have invested in over one hundred start-ups in the healthcare sector. Our healthcare investments are majorly in diagnostics, R&D, equipment, and services fields. In recent years, we started to pay close attention to AI-related "Digital Healthcare" sector. What we can bring to entrepreneurs?We are committed to finding great companies for the future to bring long-term value to people and society We share our industry resources with entrepreneurs We have a complete trust relationship with stakeholders, especially with our investors and entrepreneurs We help entrepreneurs build strong teams and provide them with consulting supports We build a unique ecosystem to provide value-added services to entrepreneurs We value important milestones including financing, IPOs and M&As We provide support to entrepreneurs when they make strategically critical decisions